Perrigo and Partner Cobrek Confirms Filing for Generic Version of Evoclin(R) and Announcement of Lawsuit ... ( ALLEGAN Mich. March 17 /- Perrigo Com...)

Perrigo and Partner Cobrek Confirms Filing for Generic Version of Evoclin(R) and Announcement of Lawsuit by Stiefel

Date:3/17/2009

ALLEGAN, Mich., March 17 /PRNewswire-FirstCall/ -- Perrigo Company (Nasdaq: PRGO; TASE) today announced that its partner Cobrek Pharmaceuticals, Inc. has filed an Abbreviated New Drug Application (ANDA) for Clindamycin Phosphate Foam 1%, a generic version of Evoclin(R) Foam 1%. The Company believes that Cobrek is the first to file an ANDA with a Paragraph IV certification against Evoclin(R).

Evoclin(R) (clindamycin phosphate) Foam 1% is a topical antibiotic indicated for topical application in the treatment of acne vulgaris, and had sales of approximately $44 million for the 12 months ended January 2009, as measured by Wolters Kluwer Health.

The ANDA for Clindamycin Phosphate Foam, 1%, which was filed prior to enactment of the Q1 Program Supplemental Funding Act of 2008 (the "Q1 Act"), was timely amended to contain a Paragraph IV Certification in accordance with the Q1 Act. On March 13, 2009, Stiefel filed suit alleging patent infringement in the United States District Court for the District of Delaware against Perrigo and its partner Cobrek. Stiefel also has filed a Citizen Petition with the U.S. Food and Drug Administration ("the FDA") seeking to have a 30 month stay of Cobrek's ANDA approval imposed. The FDA has not ruled, neither have the courts, regarding whether the Q1 Act entitles Stiefel to a 30 month stay.

Perrigo's Chairman and CEO Joseph C. Papa concluded, "This filing reflects our continuing investment in new products. We are the manufacturer and developer of this product as well as the exclusive sales and marketer. As always, Perrigo is committed to making quality healthcare more affordable for our customers and drive value for our shareholders."

Perrigo Company is a leading global healthcare supplier that develops, manufactures and distributes OTC and generic prescript
'/>"/>

SOURCE Perrigo Company
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine technology :

1. Perrigo Announces Approval for Over-the-Counter Childrens Cetirizine Oral Solution
2. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
3. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
4. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
5. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
6. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
7. The Leukemia & Lymphoma Society and Cleveland Clinic Taussig Cancer Institute Announce Groundbreaking Partnership to Accelerate Drug Approvals
8. PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs
9. JDRF and Lilly Partner to Fund Research to Identify Beta Cell Biomarkers
10. Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer
11. UNICEF Partners With Causes on Facebook to Launch Charity Gift Feature

Post Your Comments:

(Date:5/24/2013)... China Biologic Products, Inc. (Nasdaq: CBPO, "China Biologic" or ... in China , today announced that ... issued by Shanghai RAAS Blood Products Co., Ltd. ("Shanghai ... that on May 21, 2013, Ms. Siu ... shareholders of the Company, and her spouse, Mr. Tung ...

(Date:5/24/2013)... , May 24, 2013 Auxilium Pharmaceuticals, Inc. (Nasdaq: ... will participate in the Deutsche Bank Health Care Conference ... Waterfront Hotel. Mr. Adrian Adams , ... an overview of the Company and its product pipeline ... (Logo: http://photos.prnewswire.com/prnh/20101202/MM10881LOGO ) ...

(Date:5/24/2013)... YORK , May 24, 2013 In accordance ... Rules and Rule 14e-1 of the United States Exchange Act, ... its original offer for Elan Corporation (NYSE: ELN). ... Limited ("Royalty Pharma") made an offer for the entire of ... Corporation, plc ("Elan") (the "Original Offer"). On ...

[0] China Biologic Comments on the Proposed Shanghai RAAS Transaction [0] Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference [0] Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements

... InfoLogix, Inc. (Pink Sheets: IFLG ), ... the healthcare and commercial industries, announced today that it ... Faire and Regional Conference, sponsored by HIMSS South Florida ... Grand Hotel in Davies, FL (situated North of Miami) ...

... Mass., Oct. 25 GENFIT (Alternext: ALGFT; ISIN: FR0004163111), ... and development, focusing on the early diagnosis and preventive ... it has been selected by Windhover as one of ... the cardiovascular/metabolic category. This announcement is part of the ...

Cached Medicine Technology:InfoLogix to Present at South Florida Healthcare Trade Faire & Regional Conference 2 GENFIT Selected by Windhover for the 2011 'Top Biopharma Projects To Watch' 2 GENFIT Selected by Windhover for the 2011 'Top Biopharma Projects To Watch' 3

InfoLogix to Present at South Florida Healthcare Trade Faire & Regional Conference GENFIT Selected by Windhover for the 2011 'Top Biopharma Projects To Watch'

(Date:5/23/2013)... PHILADELPHIA, May 24, 2013 -- High blood glucose is ... of intensive insulin therapy (IIT) to control hyperglycemia is ... does not show a consistent benefit and even shows ... the American College of Physicians, (ACP) Clinical Guidelines Committee ... the American Journal of Medical Quality . , ...

(Date:5/23/2013)... Littleton, CO (PRWEB) May 23, 2013 ... environment, Special Operations Forces and law enforcement need an ... Night Vision Security Enhancer, Night VISER , is ... illuminator and motion sensing system to increase border and ... for Night VISER have more than tripled over the ...

(Date:5/23/2013)... May 24, 2013 In his pulse-quickening novel, ... the question, “Do you trust your government?” , In the ... killed en route to London ’s Heathrow Airport. His ... is left waiting for him to arrive at his ... death surfaces, Alan has doubts about the government’s report. When ...

(Date:5/23/2013)... Orange County film studio and visual effects ... light leaks for Apple's Final Cut Pro X today. ... no longer have to worry about matching up the movement ... Said Christina Austin, CEO of Pixel Film Studios, "You have ... look." , ProLeak from Pixel Film Studios allows users to ...

(Date:5/23/2013)... Branford, CT (PRWEB) May 23, 2013 ... patient satisfaction and perception management tools, and ASCA, ... to develop the new ASCA Benchmarking Program. ... in surveying technology and national benchmarking experience to ... with a comprehensive, state-of-the-art benchmarking tool. , “Voyance ...

Breaking Medicine News(10 mins):Health News:ACP issues recommendations for management of high blood glucose in hospitalized patients 2 Health News:Lighting Up the Night: ARA Announces Record Sales of Its Night VISER System 2 Health News:Lighting Up the Night: ARA Announces Record Sales of Its Night VISER System 3 Health News:New Book “The AIDS Covenant” by Roy Harris Delivers Intriguing, Captivating Story 2 Health News:Pixel Film Studios Releases ProLeak Light Leaks for Final Cut Pro X Today 2 Health News:Voyance and ASCA Announce Strategic Partnership to Better the ASC Industry 2 Health News:Voyance and ASCA Announce Strategic Partnership to Better the ASC Industry 3

[0] ACP issues recommendations for management of high blood glucose in hospitalized patients [0] Lighting Up the Night: ARA Announces Record Sales of Its Night VISER System [0] New Book “The AIDS Covenant” by Roy Harris Delivers Intriguing, Captivating Story [0] Pixel Film Studios Releases ProLeak Light Leaks for Final Cut Pro X Today [0] Voyance and ASCA Announce Strategic Partnership to Better the ASC Industry

... Researchers at Cambridge University in the UK have discovered ... play a significant role in triggering breast cancer in ... new methods of targeting younger women at higher-than-average risk ... with mammography before they reach 50 - the age ...

... of 'monkey see, monkey do.' Researchers at Ohio University ... red, they began to develop red and orange skin and ... such as macaques and leaf monkeys, all have trichromatic vision, ... red colors. Primatologists have disagreed about whether this type of ...

... a say in how they quit are more likely to ... new research at the University of Rochester . ... the University of Rochester School of Medicine and Dentistry, will ... demonstrate patient involvement in a quit plan leads to smokers ...

... an enzyme called Cdk5 in their brains by using the ... adept at learning and quicker at figuring out the changes ... ,"Its pretty rare that you make mice smarter, so ... senior study author Dr. James Bibb, Assistant Professor of Psychiatry, ...

... Published today in the American Diabetes Association journal Diabetes ... that the care of elderly patients with type 1insulin ... facilities fails to meet ADA Standards of Care. ... Intensity of Care?, a study authored Jay Shubrook, D.O., ...

... are the bad guys that help bacterial pathogens do their ... system. In essence, they knock down the front door of ... ,Now, researchers at the University of California, San Diego (UCSD) ... an effector protein called YpkA, one of several effectors of ...

Cached Medicine News:Health News:UK Scientists Identify Gene Mutations That Trigger Breast Cancer 2 Health News:UK Scientists Identify Gene Mutations That Trigger Breast Cancer 3 Health News:Color Vision Drove Primates to Develop Red Skin and Hair, Study Finds 2 Health News:Choice is a Key Element in Success for Smokers Who Want to Quit 2 Health News:Scientist Found New Mechanism for Brain Learning 2 Health News:Diabetics in Nursing Homes Need Improved Care 2 Health News:Diabetics in Nursing Homes Need Improved Care 3 Health News:How Plague-Causing Bacteria Disarm Host Defense 2

UK Scientists Identify Gene Mutations That Trigger Breast Cancer Color Vision Drove Primates to Develop Red Skin and Hair, Study Finds Choice is a Key Element in Success for Smokers Who Want to Quit Scientist Found New Mechanism for Brain Learning Diabetics in Nursing Homes Need Improved Care How Plague-Causing Bacteria Disarm Host Defense

... designed specifically for posteror ... injection of silicone oil ... Special high pressure tubing ... cannula. May also be ...

Product designed specifically for posteror segment surgical procedures. Facilitates posterior segment infusion. Flexible tubing 10in (25cm)....

For surgical treatment, repair and irrigation of the nasolacrimal system. Stainless steel probes, 23G x4 1/2in (.60mm x 11cm) Silicone tubing, length 14in (35cm), ID: .012in (.30mm) OD: .025in (.60mm...

...

Medicine Products:

Viscous Infusion Cannula 6mm Infusion Cannula 4mm Lacrimal Intubation Set Replacment Tubing